Antimicrobial Peptides: Their Role as Infection-Selective Tracers for Molecular Imaging
暂无分享,去创建一个
Thomas Ebenhan | Olivier Gheysens | Jan Rijn Zeevaart | O. Gheysens | M. Sathekge | T. Ebenhan | H. G. Kruger | J. Zeevaart | Hendrick Gert Kruger | Mike Machaba Sathekge
[1] Alessandro Tossi,et al. Amphipathic, α‐helical antimicrobial peptides , 2000 .
[2] Dong-Kuk Lee,et al. Mechanism of lipid bilayer disruption by the human antimicrobial peptide, LL-37. , 2003, Biochemistry.
[3] D. Wareham,et al. 99mTc-labeled antimicrobial peptides for detection of bacterial and Candida albicans infections. , 2002, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[4] E. Pauwels,et al. 99mTc-labeled antimicrobial peptides for detection of bacterial and Candida albicans infections. , 2001, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[5] Y. Shai,et al. Mode of action of membrane active antimicrobial peptides. , 2002, Biopolymers.
[6] R. Hancock,et al. Interaction of Cationic Antimicrobial Peptides with Model Membranes* , 2001, The Journal of Biological Chemistry.
[7] M. Dathe,et al. Structural features of helical antimicrobial peptides: their potential to modulate activity on model membranes and biological cells. , 1999, Biochimica et biophysica acta.
[8] F. Gemmel,et al. Clinical trial of specific imaging of infections , 2010, Nuclear medicine communications.
[9] T. Ganz. Defensins: antimicrobial peptides of innate immunity , 2003, Nature Reviews Immunology.
[10] E. Pauwels,et al. Radiopharmaceuticals: new antimicrobial agents. , 2003, Trends in biotechnology.
[11] C. Palestro. Radionuclide Imaging of Infection: In Search of the Grail , 2009, Journal of Nuclear Medicine.
[12] L. Dijkshoorn,et al. The Synthetic N-Terminal Peptide of Human Lactoferrin, hLF(1-11), Is Highly Effective against Experimental Infection Caused by Multidrug-Resistant Acinetobacter baumannii , 2004, Antimicrobial Agents and Chemotherapy.
[13] K. Matsuzaki,et al. Polar Angle as a Determinant of Amphipathic α-Helix-Lipid Interactions: A Model Peptide Study , 2000 .
[14] H. Maecke,et al. 68Ga-PET: a powerful generator-based alternative to cyclotron-based PET radiopharmaceuticals. , 2008, Contrast media & molecular imaging.
[15] O. Kuipers,et al. Use of the cell wall precursor lipid II by a pore-forming peptide antibiotic. , 1999, Science.
[16] Katsumi Matsuzaki,et al. Control of cell selectivity of antimicrobial peptides. , 2009, Biochimica et biophysica acta.
[17] S. Blondelle,et al. Lipid-induced conformation and lipid-binding properties of cytolytic and antimicrobial peptides: determination and biological specificity. , 1999, Biochimica et biophysica acta.
[18] W. Marsden. I and J , 2012 .
[19] T. Govender,et al. Preclinical Evaluation of 68Ga-Labeled 1,4,7-Triazacyclononane-1,4,7-Triacetic Acid-Ubiquicidin as a Radioligand for PET Infection Imaging , 2014, The Journal of Nuclear Medicine.
[20] M. Zasloff. Antimicrobial peptides of multicellular organisms , 2002, Nature.
[21] G. Ferro-Flores,et al. Biokinetics of (99m)Tc-UBI 29-41 in humans. , 2004, Nuclear medicine and biology.
[22] R I Lehrer,et al. Crystallization of antimicrobial pores in membranes: magainin and protegrin. , 2000, Biophysical journal.
[23] G. G. Stokes. "J." , 1890, The New Yale Book of Quotations.
[24] G. Ferro-Flores,et al. Lys and Arg in UBI: a specific site for a stable Tc-99m complex? , 2003, Nuclear medicine and biology.
[25] E. Pauwels,et al. 99mTc-Labeled UBI 29-41 peptide for monitoring the efficacy of antibacterial agents in mice infected with Staphylococcus aureus. , 2004, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[26] Michael Bienert,et al. Optimization of the antimicrobial activity of magainin peptides by modification of charge , 2001, FEBS letters.
[27] I. Nabipour,et al. Diagnostic value of 99mTc-ubiquicidin scintigraphy for osteomyelitis and comparisons with 99mTc-methylene diphosphonate scintigraphy and magnetic resonance imaging , 2011, Nuclear medicine communications.
[28] A. Signore,et al. Receptor targeting agents for imaging inflammation/infection: where are we now? , 2006, The Quarterly Journal of Nuclear Medicine and Molecular Imaging.
[29] P. Nibbering,et al. Ubiquicidin, a novel murine microbicidal protein present in the cytosolic fraction of macrophages , 1999, Journal of leukocyte biology.
[30] Eduardo Guaní-Guerra,et al. Antimicrobial peptides: general overview and clinical implications in human health and disease. , 2010, Clinical immunology.
[31] Miss A.O. Penney. (b) , 1974, The New Yale Book of Quotations.
[32] Huey W. Huang,et al. Action of antimicrobial peptides: two-state model. , 2000, Biochemistry.
[33] B D Sykes,et al. Dissociation of Antimicrobial and Hemolytic Activities in Cyclic Peptide Diastereomers by Systematic Alterations in Amphipathicity* , 1999, The Journal of Biological Chemistry.
[34] B. Neumeister,et al. Staphylococcus aureus strains lacking D-alanine modifications of teichoic acids are highly susceptible to human neutrophil killing and are virulence attenuated in mice. , 2002, The Journal of infectious diseases.
[35] M. Pomper,et al. The evolution of imaging in cancer: current state and future challenges. , 2011, Seminars in oncology.
[36] A. Tossi,et al. Amphipathic alpha helical antimicrobial peptides. , 2001, European journal of biochemistry.
[37] A. Ianoul,et al. Imaging the membrane lytic activity of bioactive peptide latarcin 2a. , 2012, Biochimica et biophysica acta.
[38] T. Govender,et al. Peptide synthesis, characterization and ⁶⁸Ga-radiolabeling of NOTA-conjugated ubiquicidin fragments for prospective infection imaging with PET/CT. , 2014, Nuclear medicine and biology.
[39] John B. Shoven,et al. I , Edinburgh Medical and Surgical Journal.
[40] M. Assadi,et al. Role of 99mTc-ubiquicidin 29–41 scintigraphy to monitor antibiotic therapy in patients with orthopedic infection: a preliminary study , 2011, Nuclear medicine communications.
[41] H. Jörnvall,et al. The human antimicrobial and chemotactic peptides LL-37 and alpha-defensins are expressed by specific lymphocyte and monocyte populations. , 2000, Blood.
[42] H. Vogel,et al. Diversity of antimicrobial peptides and their mechanisms of action. , 1999, Biochimica et biophysica acta.
[43] A. Tossi,et al. Alpha-helical antimicrobial peptides--using a sequence template to guide structure-activity relationship studies. , 2006, Biochimica et biophysica acta.
[44] L. Yang,et al. Barrel-stave model or toroidal model? A case study on melittin pores. , 2001, Biophysical journal.
[45] R. Nagaraj,et al. Interaction of antimicrobial peptides with biological and model membranes: structural and charge requirements for activity. , 1999, Biochimica et biophysica acta.
[46] Michael R. Yeaman,et al. Mechanisms of Antimicrobial Peptide Action and Resistance , 2003, Pharmacological Reviews.
[47] W. Oyen,et al. Radiopharmaceuticals for scintigraphic imaging of infection and inflammation , 2001, Inflammation Research.
[48] W. Oyen,et al. Imaging infection/inflammation in the new millennium , 2001, European Journal of Nuclear Medicine.
[49] S. Vallabhajosula,et al. Clinically proven radiopharmaceuticals for infection imaging: mechanisms and applications. , 2009, Seminars in nuclear medicine.
[50] K. Matsuzaki. Why and how are peptide-lipid interactions utilized for self-defense? Magainins and tachyplesins as archetypes. , 1999, Biochimica et biophysica acta.
[51] C. Brouwer,et al. Discovery and development of a synthetic peptide derived from lactoferrin for clinical use , 2011, Peptides.
[52] E. Krause,et al. Peptide hydrophobicity controls the activity and selectivity of magainin 2 amide in interaction with membranes. , 1997, Biochemistry.
[53] Andreas Peschel,et al. How do bacteria resist human antimicrobial peptides? , 2002, Trends in microbiology.
[54] M. Assadi,et al. Technetium-99m-ubiquicidin scintigraphy in the detection of infective endocarditis. , 2014, Hellenic journal of nuclear medicine.
[55] I. Nabipour,et al. Diagnostic value of 99mTc-ubiquicidin scintigraphy for osteomyelitis and comparisons with 99mTc-methylene diphosphonate scintigraphy and magnetic resonance imaging , 2011, Nuclear medicine communications.
[56] D. Rijkers,et al. Membrane-Spanning Peptides Induce Phospholipid Flop: A Model for Phospholipid Translocation across the Inner Membrane of E. coli , 2001 .
[57] D. Wareham,et al. Technetium-99m labelled antimicrobial peptides discriminate between bacterial infections and sterile inflammations , 2000, European Journal of Nuclear Medicine.
[58] M. Imran,et al. Antimicrobial peptide 99mTc-ubiquicidin 29-41 as human infection-imaging agent: clinical trial. , 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[59] K. Brogden. Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria? , 2005, Nature Reviews Microbiology.
[60] S. K. Shukla,et al. Structural determinants of host defense peptides for antimicrobial activity and target cell selectivity. , 2010, Biochimie.
[61] W. Maloy,et al. Structure–activity studies on magainins and other host defense peptides , 1995, Biopolymers.
[62] Jonathan Cohen,et al. A prospective study of fever in the intensive care unit , 1999, Intensive Care Medicine.
[63] A. Gholamrezanezhad,et al. 99mtc-Ubiquicidin [29–41], a Promising Radiopharmaceutical to Differentiate Orthopedic Implant Infections from Sterile Inflammation , 2013, Iranian journal of pharmaceutical research : IJPR.
[64] A. Peschel,et al. Key Role of Teichoic Acid Net Charge inStaphylococcus aureus Colonization of Artificial Surfaces , 2001, Infection and Immunity.
[65] J. Bading,et al. Integrin αβ3-Targeted Imaging of Lung Cancer , 2005 .
[66] E. Pauwels,et al. Technetium-99m labelled antimicrobial peptides discriminate between bacterial infections and sterile inflammations , 2000, European Journal of Nuclear Medicine.
[67] M. Yeaman,et al. Multidimensional signatures in antimicrobial peptides. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[68] R. Sadeghi,et al. (99m)Tc-labeled ubiquicidin scintigraphy: a promising method in hip prosthesis infection diagnosis. , 2012, Nuklearmedizin. Nuclear medicine.
[69] J. Meller,et al. The role of nuclear medicine in infection and inflammation. , 2001, The Lancet. Infectious diseases.
[70] E. Pauwels,et al. Peptide radiopharmaceuticals in nuclear medicine , 1999, European Journal of Nuclear Medicine.
[71] C. Brouwer,et al. The pharmacology of radiolabeled cationic antimicrobial peptides. , 2008, Journal of pharmaceutical sciences.
[72] W. Burchert,et al. Comparison of 99mTc- and 18F-Ubiquicidin Autoradiography to Anti–Staphylococcus aureus Immunofluorescence in Rat Muscle Abscesses , 2008, Journal of Nuclear Medicine.
[73] J. M. Sanderson,et al. Peptide-lipid interactions: insights and perspectives. , 2005, Organic & biomolecular chemistry.
[74] Subhani M Okarvi,et al. Peptide‐based radiopharmaceuticals: Future tools for diagnostic imaging of cancers and other diseases , 2004, Medicinal research reviews.
[75] A. Alavi,et al. Positron emission tomography as a diagnostic tool in infection: present role and future possibilities. , 2009, Seminars in nuclear medicine.
[76] Oscar P. Kuipers,et al. Specific Binding of Nisin to the Peptidoglycan Precursor Lipid II Combines Pore Formation and Inhibition of Cell Wall Biosynthesis for Potent Antibiotic Activity* , 2001, The Journal of Biological Chemistry.
[77] G. Ferro-Flores,et al. In vitro and in vivo assessment of 99mTc-UBI specificity for bacteria. , 2003, Nuclear medicine and biology.